For decades, biopharma executives have seen operational costs and complexities soar. As commercial pricing, reimbursement, and market access hurdles remain particularly difficult to overcome, CEOs are ...
Among all the priorities in organizational learning and development, leadership education has garnered the lion’s share of attention. Over the past several decades, countless books, learning theories ...
As requested in Section 1544 of the FY2025 National Defense Authorization Act, a National Academies of Sciences, Engineering, and Medicine consensus study will conduct an "evaluation of alternative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results